Because we have recently shown that drebrin is instead highly expressed in high grade invasive tumors compared to low grade superficial and normal controls [18], these results might indicate that progranulin downstream effectors, such as drebrin or the unidentified progranulin receptor, are likely better predictor of tumor progression than progranulin itself. Here, DBN1 is linked to neoplasm.